What is the recommended treatment for Enterococcal infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Enterococcal Infections

The recommended first-line treatment for enterococcal infections is a combination of ampicillin or penicillin G with gentamicin for susceptible strains, with treatment duration of 4-6 weeks for endocarditis and shorter courses for other infections based on clinical response. 1

Treatment Algorithm Based on Susceptibility

For Penicillin/Ampicillin-Susceptible Enterococci:

  • First-line therapy:

    • Ampicillin 2g IV every 4 hours (or 200 mg/kg/day divided every 6 hours) 2
    • PLUS gentamicin 15 mg/kg/day IV/IM in 2-3 divided doses 1
    • Duration: 4-6 weeks for endocarditis; 7-14 days for uncomplicated infections 2
  • Alternative for aminoglycoside-resistant strains:

    • Ampicillin 2g IV every 4 hours
    • PLUS ceftriaxone 2g IV every 12 hours 1
    • Duration: 6 weeks regardless of symptom duration 1

For Penicillin-Allergic Patients:

  • Vancomycin 30 mg/kg/day IV in 2 divided doses
  • PLUS gentamicin 15 mg/kg/day IV/IM in 2 divided doses 1, 2
  • Duration: 6 weeks for endocarditis 1

For Vancomycin-Resistant Enterococci (VRE):

  • First-line:

    • High-dose daptomycin 8-12 mg/kg IV daily (preferred for bloodstream infections) 1, 2
    • Consider combination with β-lactams for high daptomycin MICs 2
  • Alternatives:

    • Linezolid 600 mg IV/PO every 12 hours 1, 3
    • Tigecycline 100 mg IV loading dose, then 50 mg IV every 12 hours (for intra-abdominal infections) 1

For Uncomplicated Urinary Tract Infections due to VRE:

  • Single-dose fosfomycin 3g PO 1
  • OR nitrofurantoin 100 mg PO every 6 hours 1
  • OR high-dose ampicillin (if susceptible) 1

Special Considerations

For Endocarditis:

  • Native valve endocarditis: 4-6 weeks of therapy 1
  • Prosthetic valve endocarditis: Minimum 6 weeks of therapy 1
  • For symptoms <3 months: 4 weeks may be sufficient if using ampicillin-gentamicin 1
  • For symptoms >3 months: 6 weeks recommended 1

For Specific Infection Sites:

  • Bloodstream infections: 10-14 days of therapy 2
  • Intra-abdominal infections: Tigecycline is an effective option for VRE 1
  • Urinary tract infections: Shorter courses (7-10 days) are typically sufficient 2

Monitoring and Precautions

  • Monitor renal function weekly with aminoglycoside therapy 1, 2
  • For daptomycin, monitor creatine kinase (CK) levels regularly 2
  • Streptomycin should be avoided in patients with creatinine clearance <50 mL/min 1
  • Enterococci are intrinsically resistant to cephalosporins when used alone 2

Important Caveats

  • Infectious disease consultation is strongly recommended for management of enterococcal endocarditis 1
  • Combination therapy is necessary for bactericidal activity against enterococci 2, 4
  • Cephalosporins alone are ineffective against enterococci 2, 5
  • Enterococcal superinfection can occur after cephalosporin therapy 5
  • The ampicillin-ceftriaxone combination has shown promising results for orthopedic infections due to E. faecalis 6
  • Treatment duration should never be shortened below recommended minimums, as this may lead to treatment failure 2

For severe infections, especially endocarditis, the synergistic combination of cell wall-active agents with aminoglycosides remains the cornerstone of therapy, with ampicillin-ceftriaxone emerging as an effective alternative for aminoglycoside-resistant strains 1, 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Enterococcal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Enterococcal endocarditis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992

Research

Clinical manifestations of enterococcal infection.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1990

Research

Therapy of enterococcal infections.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.